Diality
Versatile Hemodialysis Technology
Versatile Hemodialysis Technology
Diality is a privately held medical device company established in 2015, headquartered in the United States. The company's mission is to develop solutions that enhance the care and quality of life for patients with kidney disease. Diality's flagship product is the Moda-flx Hemodialysis System, a user-friendly, mobile, and connected platform that aims to maximize clinical flexibility. It achieves this by combining the prescription capabilities of in-center systems with the ease of use offered by next-generation hemodialysis devices. Their latest Series C investment amounted to $28.00M and was secured on 09 August 2023. The identity of the investors in this last investment round is currently undisclosed.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series C | $28.00M | - | 09 Aug 2023 | |
| Series B | $24.00M | - | 02 Mar 2022 | |
| Series B | $12.50M | - | 20 Oct 2020 | |
| Series A | $10.00M | - | 12 Jun 2019 | |
| Seed Round | $8.00M | - | 29 Jun 2018 |
No recent news or press coverage available for Diality.
We care about your data, and we'd love to use cookies make your experience better.
